Latest Regulatory News

Assetora Limited is set to be delisted from the ASX after a two-year suspension, with the company exploring a fresh listing on the National Stock Exchange of Australia to better suit its evolving business model.

BPH Global has clarified the timing and rationale behind its disclosure of a binding Memorandum of Understanding with Indonesia’s National Research and Innovation Agency, confirming compliance with ASX rules.

Podium Minerals has disclosed the initial securities interests of its newly appointed directors, highlighting a significant allocation of performance rights to Gary Humphries while Neal Froneman holds none.

Invex Therapeutics reports a net loss of $715,582 for H1 2026 while advancing its Exenatide program targeting neurological diseases, alongside notable board reshuffles.

Australian Vanadium Limited has responded to an ASX price query following a sharp rise in its share price and trading volume, denying any undisclosed information behind the market activity.

Finder Energy Holdings has clarified that its recent share price jump is driven by investor enthusiasm around key project milestones, dismissing any undisclosed information as a cause.

Betmakers Technology Group has addressed an ASX price query following a surge in its share price linked to media reports of potential M&A interest from Tabcorp. The company confirms compliance with continuous disclosure rules and has authorised its response through its board.

ADX Energy has restarted flow testing at its Welchau-1 well in Austria after regulatory delays, aiming to confirm the commercial viability of light oil and gas-condensate reservoirs in the Reifling Formation.

Paladin Energy reported a 16% increase in uranium production and a significant rise in sales volumes for the December 2025 quarter, alongside a successful equity raise and debt restructuring that enhance its financial flexibility.

Peel Mining has agreed to sell its South Cobar Copper Project to Aeris Resources in a $214 million transaction, while spinning off its remaining assets into a new ASX-listed company, NewCo. The deal offers Peel shareholders immediate value and ongoing exposure to a diversified metals portfolio.

Pro Medicus has reported its strongest half-year performance yet, with revenue and profits surging alongside a wave of new multi-million dollar contracts and strategic AI investments. The healthcare IT leader is expanding its global footprint and cloud capabilities, setting the stage for sustained growth.

Aguia Resources is poised to commence production at its Tres Estradas phosphate mine with infrastructure nearly complete and key licenses expected imminently. Meanwhile, exploration at the nearby Passo Feio project reveals promising phosphate grades, underpinning a strong market outlook amid global supply constraints.